Transgenic Mouse Core
- Institution
- BOSTON CHILDREN'S HOSPITAL, MA
- Principal investigator
- Jay K Kolls
- Funding
- $313K
- Duration
- 2025–2030
Moonbase score
Still being scored
Abstract
Core 3. Transgenic Mouse Core Abstract Genetically engineered mice have been essential tools to study the function of immune genes in mammals. To support the overall goals of the “Immunization against Multidrug-resistant Pathogens: Activating T Cell Immunity” Center of Excellence for Translational Research (IMPACT-CETR) and to control for the gut microbiota that could influence results, we have centralized breeding of mice in the Transgenic Mouse Core. The Transgenic Mouse will supply genetically engineered mice for the research projects. The overall coordination of breeding animals will be through this core. Specific Aims are: 1) To monitor and maintain genetically engineered lines for the projects. 2) To coordinate breeding and shipment demands with the project leaders. 3) To provide assay support for genotyping as well as tissue specific recombination for conditional knockout lines.
LOADING MOONBASE SCORE
Questions for BOSTON CHILDREN'S HOSPITAL
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Tulane University of Louisiana45
Improved Therapeutics and Diagnostics for Pneumocystis Pneumonia
Jay K Kolls · $469K · 2016–2026
- NIH · Tulane University of LouisianaNot yet scored
CD4+ T cell Immunity in the Respiratory Tract
Jay K Kolls · $1.1M · 2025–2032
- NIH · Boston Children'S HospitalNot yet scored
Vaccines for Klebsiella
Jay K Kolls · $729K · 2025–2030